Taken together, these observations show that CK2 inhibition can modulate the intracellular functions of all three main CK2 targets, Akt/Stat3/NFκB, in human AML cells both through modulation of phosphorylation/activation and modulation of intracellular compartmentalization for certain pathway proteins. The gene discussed is STAT3; the disease is acute myeloid leukemia.